Boston Scientific (BSX) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)
Boston Scientific (BSX) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 5.69% |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn | 2.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.21% |
| Mar 31, 2026 | 19.89% |
| Dec 31, 2025 | 22.53% |
| Sep 30, 2025 | 23.54% |
| Jun 30, 2025 | 17.28% |
| Mar 31, 2025 | 16.98% |
| Dec 31, 2024 | 15.22% |
| Sep 30, 2024 | 16.58% |
| Jun 30, 2024 | 16.46% |
| Mar 31, 2024 | 16.91% |
| Dec 31, 2023 | 16.88% |
| Sep 30, 2023 | 15.93% |
| Jun 30, 2023 | 12.82% |
| Mar 31, 2023 | 9.40% |
| Dec 31, 2022 | 8.61% |
| Sep 30, 2022 | 7.78% |
| Jun 30, 2022 | 7.88% |
| Mar 31, 2022 | 10.33% |
| Dec 31, 2021 | 8.06% |
| Sep 30, 2021 | 2.18% |